Moran Artzi1,2, Gilad Liberman1, Deborah T Blumenthal2,3, Felix Bokstein2,3, Orna Aizenstein1,2, Dafna Ben Bashat4,5,6. 1. Sagol Brain Institute, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel. 2. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. 3. Neuro-Oncology Service, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. 4. Sagol Brain Institute, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel. dafnab@tlvmc.gov.il. 5. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. dafnab@tlvmc.gov.il. 6. Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel. dafnab@tlvmc.gov.il.
Abstract
PURPOSE: To study the repeatability of plasma volume (vp) extracted from dynamic-contrast-enhanced (DCE) MRI in order to define threshold values for significant longitudinal changes, and to assess changes in patients with high-grade-glioma (HGG). METHODS: Twenty eight healthy subjects, of which eleven scanned twice, were used to assess the repeatability of vp within the normal-appearing brain tissue and to define threshold values for significant changes based on least-detected-differences (LDD) of mean vp values and histogram comparisons using earth-mover's-distance (EMD). Sixteen patients with HGG were scanned longitudinally with eight patients scanned before and following bevacizumab therapy. Longitudinal changes were assessed based on defined threshold values in comparison to RANO criteria. RESULTS: The threshold values for significant changes were: LDD = 0.0024 (ml/100 ml, 21%) for mean vp and EMD = 4.14. In patients, in 20/24 comparisons, no significant longitudinal changes were detected for vp within the normal-appearing brain tissue. Concurring results were obtained between changes in lesion volume (RANO criteria) and LDD or EMD values in cases diagnosed with progressive-disease, yet in about 50% of cases diagnosed with partial-response preliminary results demonstrated significant increase in vp despite significant reductions in lesion volume. In two patients, these changes preceded progression detected at follow-up scans. In general, a good concordance was obtained between LDD and EMD. CONCLUSION: This study shows high repeatability of vp and provides threshold values for significant changes in longitudinal assessment of patients with brain tumors. Preliminary results suggest the use of vp-DCE parameter to improve assessment of therapy response in patients with high-grade-glioma.
PURPOSE: To study the repeatability of plasma volume (vp) extracted from dynamic-contrast-enhanced (DCE) MRI in order to define threshold values for significant longitudinal changes, and to assess changes in patients with high-grade-glioma (HGG). METHODS: Twenty eight healthy subjects, of which eleven scanned twice, were used to assess the repeatability of vp within the normal-appearing brain tissue and to define threshold values for significant changes based on least-detected-differences (LDD) of mean vp values and histogram comparisons using earth-mover's-distance (EMD). Sixteen patients with HGG were scanned longitudinally with eight patients scanned before and following bevacizumab therapy. Longitudinal changes were assessed based on defined threshold values in comparison to RANO criteria. RESULTS: The threshold values for significant changes were: LDD = 0.0024 (ml/100 ml, 21%) for mean vp and EMD = 4.14. In patients, in 20/24 comparisons, no significant longitudinal changes were detected for vp within the normal-appearing brain tissue. Concurring results were obtained between changes in lesion volume (RANO criteria) and LDD or EMD values in cases diagnosed with progressive-disease, yet in about 50% of cases diagnosed with partial-response preliminary results demonstrated significant increase in vp despite significant reductions in lesion volume. In two patients, these changes preceded progression detected at follow-up scans. In general, a good concordance was obtained between LDD and EMD. CONCLUSION: This study shows high repeatability of vp and provides threshold values for significant changes in longitudinal assessment of patients with brain tumors. Preliminary results suggest the use of vp-DCE parameter to improve assessment of therapy response in patients with high-grade-glioma.
Entities:
Keywords:
DCE-MRI; Earth mover’s distance (EMD); High grade brain tumors; Least detected changes (LDD); Plasma volume (v p)
Authors: Tobias Heye; Matthew S Davenport; Jeffrey J Horvath; Sebastian Feuerlein; Steven R Breault; Mustafa R Bashir; Elmar M Merkle; Daniel T Boll Journal: Radiology Date: 2012-12-06 Impact factor: 11.105
Authors: Hassan Bagher-Ebadian; Rajan Jain; Siamak P Nejad-Davarani; Tom Mikkelsen; Mei Lu; Quan Jiang; Lisa Scarpace; Ali S Arbab; Jayant Narang; Hamid Soltanian-Zadeh; Ramesh Paudyal; James R Ewing Journal: Magn Reson Med Date: 2011-11-29 Impact factor: 4.668
Authors: Tobias Heye; Elmar M Merkle; Caecilia S Reiner; Matthew S Davenport; Jeffrey J Horvath; Sebastian Feuerlein; Steven R Breault; Peter Gall; Mustafa R Bashir; Brian M Dale; Atilla P Kiraly; Daniel T Boll Journal: Radiology Date: 2012-12-06 Impact factor: 11.105
Authors: Kourosh Jafari-Khouzani; Kyrre E Emblem; Jayashree Kalpathy-Cramer; Atle Bjørnerud; Mark G Vangel; Elizabeth R Gerstner; Kathleen M Schmainda; Kamran Paynabar; Ona Wu; Patrick Y Wen; Tracy Batchelor; Bruce Rosen; Steven M Stufflebeam Journal: Transl Oncol Date: 2015-06 Impact factor: 4.243
Authors: Otto M Henriksen; María Del Mar Álvarez-Torres; Patricia Figueiredo; Gilbert Hangel; Vera C Keil; Ruben E Nechifor; Frank Riemer; Kathleen M Schmainda; Esther A H Warnert; Evita C Wiegers; Thomas C Booth Journal: Front Oncol Date: 2022-03-03 Impact factor: 5.738
Authors: Cristina Granziera; Jens Wuerfel; Frederik Barkhof; Massimiliano Calabrese; Nicola De Stefano; Christian Enzinger; Nikos Evangelou; Massimo Filippi; Jeroen J G Geurts; Daniel S Reich; Maria A Rocca; Stefan Ropele; Àlex Rovira; Pascal Sati; Ahmed T Toosy; Hugo Vrenken; Claudia A M Gandini Wheeler-Kingshott; Ludwig Kappos Journal: Brain Date: 2021-06-22 Impact factor: 13.501
Authors: Ryan T Woodall; Prativa Sahoo; Yujie Cui; Bihong T Chen; Mark S Shiroishi; Cristina Lavini; Paul Frankel; Margarita Gutova; Christine E Brown; Jennifer M Munson; Russell C Rockne Journal: Neurooncol Adv Date: 2021-11-22
Authors: Thomas C Booth; Evita C Wiegers; Esther A H Warnert; Kathleen M Schmainda; Frank Riemer; Ruben E Nechifor; Vera C Keil; Gilbert Hangel; Patrícia Figueiredo; Maria Del Mar Álvarez-Torres; Otto M Henriksen Journal: Front Oncol Date: 2022-02-28 Impact factor: 5.738
Authors: Jan Petr; Louise Hogeboom; Pavel Nikulin; Evita Wiegers; Gwen Schroyen; Jesper Kallehauge; Marek Chmelík; Patricia Clement; Ruben E Nechifor; Liviu-Andrei Fodor; Philip C De Witt Hamer; Frederik Barkhof; Cyril Pernet; Maarten Lequin; Sabine Deprez; Radim Jančálek; Henk J M M Mutsaerts; Francesca B Pizzini; Kyrre E Emblem; Vera C Keil Journal: MAGMA Date: 2021-12-17 Impact factor: 2.310